Latest by
-
Hyundai Marine & Fire Insurance Announces Open Recruitment for New Graduates 현대해상이 2026년 전문대졸 신입사원 공개채용을 실시한다.현대해상은 전문대학 졸업자와 졸업예정자를 대상으로 신입사원을 모집한다고 27일 밝혔다.지원서는 오는 8월 10일 오후 6시까지 현대해상 채용 홈페이지를 통해 접수할 수 있다. 채용 절차는 서류전형, 1차 면접, 최종면접 순으로 진행되며 최종 합격자는 오는 11월 1일 입사한다.입사자는 배치 직무에 따라 지점 총무 또는 자동차보험 소액보상 업무를 담당하게 된다.현대해상은 지원자들의 직무 이해를 돕기 위해 오는 31일 오전 10시 온라인 채용상담회를 개최한다. 상담회에서는 온라인 가상공간에서 직무별 현직자와 실시간 질의응답을 진행할 수 있으며 별도의 사전 신청 없이 참여 가능하다.현대해상 관계자는 "기업문화 핵심가치인 정도, 탁월, 실행, 존중, 신뢰를 바탕으로 고객지향적인 마인드와 책임감을 갖춘 우수 인재를 지속적으로 발굴하고 있다"며 "현대해상의 새로운 미래를 함께 만들어갈 인재들의 많은 관심과 지원을 바란다"고 말했다.* This article has been translated by AI. 2026-07-27 10:00:00 -
Naver Announces $1 Billion Capital Increase with Nvidia, Shares Surge Over 9% Naver's shares surged over 9% in early trading after the company announced a $1 billion capital increase through a third-party allocation to Nvidia and plans to jointly build a global AI factory. This strategic partnership aims to enhance its AI infrastructure business and has improved investor sentiment, especially as Naver also plans to buy back shares.As of 9:28 a.m. on July 27, Naver's stock was trading at 226,500 won, up 19,000 won (9.16%) from the previous trading day. The stock opened at 228,500 won and reached a high of 234,500 won during the session, before slightly retracting but maintaining a strong performance around 9%.According to a filing with the Financial Supervisory Service, Naver will issue 7,241,564 new common shares at 204,500 won each to Nvidia as part of the $1 billion capital increase, equivalent to approximately 1.46 trillion won. This marks Naver's first third-party allocation since its listing on the KOSPI in 2008.The initiative is designed to address the surging global demand for AI infrastructure by establishing a strategic partnership with Nvidia to jointly build a large-scale global AI factory, aiming to seize business opportunities in the global AI compute market.Naver plans to lead the acquisition, construction, and operation of data center sites for the AI factory, while Nvidia will supply graphics processing units (GPUs).A proposed $9 billion (approximately 13.16 trillion won) computing infrastructure will be developed by Brookfield, a global alternative investment firm. Naver has selected Brookfield as the exclusive preferred negotiator and is in discussions to finalize the contract.Naver explained that the expected benefits of this project include securing new revenue sources through the operation of the AI factory in response to global AI infrastructure demand and identifying opportunities for future business collaboration with Nvidia to acquire the latest computing infrastructure.However, Naver noted potential challenges, including uncertainties in securing local data center sites and regulatory environments in various countries, as well as possible delays in securing power infrastructure and fluctuations in global AI infrastructure supply, along with potential changes in contract terms or timelines during negotiations.Naver also announced plans to buy back 4,901,094 common shares worth 1.017 trillion won on August 3. 2026-07-27 10:00:00
-
Single-Stock Leveraged ETFs Impacting Korean Market May Spread to Japan, Kioxia Targeted A single-stock leveraged exchange-traded fund (ETF) that has increased volatility among semiconductor stocks in the Korean market is showing signs of spreading to Japan. Concerns are rising that the launch of products tracking Kioxia Holdings' daily stock returns at double or negative double rates in the U.S. could further amplify volatility.According to Bloomberg on the 26th, U.S. asset management firms including Cogent Strategies, GraniteShares Advisors, and Turtle Capital Management are preparing to launch single-stock leveraged ETFs based on Kioxia shares or American Depositary Receipts (ADRs).Documents submitted to U.S. financial authorities indicate that at least nine ETFs are awaiting approval, designed to track Kioxia's daily returns at double rates or to generate double returns when the stock price declines. According to Bloomberg, Kioxia is the first Japanese company to serve as the underlying asset for a single-stock leveraged ETF.Turtle Capital plans to launch the 'T-Rex 2x Long Kioxia Daily Target ETF' as early as next month. Matthew Turtle, CEO of Turtle Capital, stated, "There are many interesting Japanese companies that U.S. investors want to access, and Japan will be the next wave of single-stock leveraged products."The issue is that Kioxia is already one of the most volatile companies among major Japanese stocks. Kioxia reached the top of Japan's market capitalization in early June, driven by expectations for AI semiconductor investments, but its market cap quickly halved as concerns over AI investment overheating spread.Experts warn that once single-stock leveraged ETFs begin trading, Kioxia's stock price fluctuations could be further amplified. Leveraged ETFs adjust their holdings of stocks, futures, options, and swaps daily to track the underlying asset's daily returns at a certain multiple.This process involves buying more of the underlying asset when the stock price rises and reducing holdings when the price falls. Bloomberg explains that if hedge funds and market makers engage in trading ahead of expected rebalancing, existing price trends could be significantly magnified in one direction.Andrew Jackson, head of Japanese equity strategy at Ortus Advisors, noted, "Leveraged ETFs distort normal market functioning and significantly increase volatility, especially amplifying excessive movements seen in AI-related stocks."The Korean market is cited as having experienced the side effects of single-stock leveraged products first. Large amounts of capital flowed into products tracking Samsung Electronics and SK Hynix, increasing volatility in related stocks, prompting Korean financial authorities to halt new listings of single-stock products.Over the past 30 trading days, the annualized volatility of the KOSPI index has exceeded 75%. In comparison, the Nikkei 225 index has seen volatility at 37%, the Hong Kong Hang Seng index at 22%, and the U.S. S&P 500 index at 13%.In Japan, the listing of leveraged ETFs tracking individual stocks is not permitted due to failure to meet diversification requirements. However, Japanese investors can trade related products listed on overseas markets, including the U.S., through local securities firms.The interest of U.S. asset managers is not limited to Kioxia. They are also preparing to launch single-stock leveraged ETFs tracking SoftBank Group, Nintendo, Tokyo Electron, Toyota Motor, Fujikura, and Lasertec.* This article has been translated by AI. 2026-07-27 09:56:00
-
President Lee's Approval Rating Slightly Drops to 46.3% President Lee Jae-myung's approval rating has fallen for the second consecutive week, reaching 46.3%, according to a public opinion survey released on July 27. The survey, conducted by Realmeter at the request of Energy Economy News from July 20 to 24, involved 2,505 respondents aged 18 and older nationwide. The positive evaluation of President Lee's performance decreased by 2.1 percentage points from the previous week. Negative evaluations rose by 1.5 percentage points to 49.5%, with the gap between positive and negative responses standing at 3.2 percentage points, within the margin of error (±2.0 percentage points at a 95% confidence level). The percentage of respondents who answered 'don't know' was 4.2%. Regionally, the approval rating in Daegu and North Gyeongsang Province dropped by 16.8 percentage points to 30.1%. In Jeonnam, Gwangju, and Jeonbuk, it fell by 5.1 percentage points to 74.6%, while in Incheon and Gyeonggi, it decreased by 2.4 percentage points to 45.5%. Conversely, in Daejeon, Sejong, and Chungcheong, it increased by 4.2 percentage points to 42.3%. By age group, the most significant decline was among those aged 70 and older, which dropped by 10.3 percentage points to 40.9%. The approval rating for those in their 40s fell to 51.2%, down 4.3 percentage points, while the rating for those in their 20s decreased by 2.7 percentage points to 32.8%. In contrast, the approval rating for those in their 30s rose by 4.5 percentage points to 39.3%. In terms of ideological orientation, the approval rating among moderates decreased by 1.8 percentage points to 49.2%, and among progressives, it fell by 1.6 percentage points to 67.9%. In a separate survey conducted on July 23-24 among 1,001 eligible voters aged 18 and older regarding party support, the Democratic Party recorded 41.3%, while the People Power Party stood at 40.6%. The Democratic Party's support decreased by 1.8 percentage points, while the People Power Party's support increased by 0.6 percentage points. Support for the Justice Reform Party was at 3.3%, the Reform Party at 2.2%, and the Progressive Party at 1.0%. The percentage of undecided voters was 9.6%. Both surveys were conducted using a wireless automated response method. The margin of error for the presidential approval rating survey is ±2.0 percentage points at a 95% confidence level, with a response rate of 3.6%. The margin of error for the party support survey is ±3.1 percentage points at a 95% confidence level, with a response rate of 4.3%. For more details, please refer to the website of the National Election Survey Deliberation Commission.* This article has been translated by AI. 2026-07-27 09:52:00
-
Wall Street Advises to Sell U.S. AI Stocks and Invest in China As global tech stocks face a correction, international investors are being advised to increase their exposure to China's AI industry.Notable Wall Street investors, including Michael Burry, Citigroup, Goldman Sachs, Allianz, and Quantum Strategies, have expressed positive outlooks on the Chinese stock market, according to the Shanghai Securities News on July 27. The report noted that foreign investors are expanding their stakes in Chinese assets amid a global market correction this month.Michael Burry, known for betting against the U.S. housing market before the 2008 financial crisis and the subject of the film 'The Big Short,' stated on social media, "Now is the time to discover growth stocks in the undervalued Hong Kong market," revealing that he has increased his stake in JD.com earlier this month. JD.com is a major Chinese e-commerce company aggressively investing in AI and humanoid technology.On July 20, Citigroup upgraded its investment stance on the Chinese stock market from 'strategic neutral' to 'overweight.' Goldman Sachs also noted in a recent report that "the Chinese AI industry has emerged as a significant investment target." Allianz added that "the growth of China's AI and advanced technology sectors will lead to improvements in the fundamentals of the Chinese economy," explaining that advanced industries are becoming a key driver of economic growth, supported by the government's proactive fiscal policies and increasing market risk appetite.Additionally, a recent report from Quantum Strategies, a Wall Street research firm, has gained attention in China. The report recommends reducing exposure to major U.S. tech stocks while increasing investments in Chinese AI applications. It stated, "Over the past two years, the valuations of U.S. big tech companies have reached historical highs, while the Chinese AI market is moving beyond large model (LLM) competition to actual industrial applications. As model performance becomes more standardized, future value will be generated in application areas, and China, with the world's largest industrial ecosystem and user base, is poised to be the biggest beneficiary of the expansion of the AI application market." 2026-07-27 09:48:00
-
Korea Technology Guarantee Fund Supports K-Venture Global Expansion in Silicon Valley The Korea Technology Guarantee Fund announced on July 27 that it held a 'Global K-Venture Innovation Meeting' on July 24 in Silicon Valley, California, at the Startup Venture Campus (SVC).This event was organized to support the overseas expansion of promising domestic startups in line with the government's global entrepreneurship and venture promotion policies, and to create a field-centered global growth ecosystem.Attendees included Noh Yong-seok, the acting minister of the Ministry of SMEs and Startups, representatives from Stanford University's accelerator, and the United Korean Founders (UKF). Officials from companies entering Silicon Valley, such as RnR, Witzgen Biotechnology, Buddy Lab, Donghae Hyung, Bestpex, Friendly AI, and Stratio Korea, were also present.Noh emphasized in his opening remarks, "We will actively support the scale-up of companies entering the global market by strengthening the connection between technology finance and investment. We will enhance communication with ventures and startups in the U.S. and work to create a field-centered global growth ecosystem."A showcase introducing innovative products from outstanding startups was also held. Prior to the meeting, the showcase featured promising startups selected by Stanford's accelerator and companies partnered with the Korea Technology Guarantee Fund, showcasing various innovative products, including K-beauty and K-food.Park Joo-sun, executive director of the Korea Technology Guarantee Fund, stated, "This meeting was a meaningful opportunity to establish a collaborative network among local companies, overseas related organizations, and experts in conjunction with the Ministry of SMEs and Startups." He added, "We will continue to strengthen our comprehensive support system that links technology finance with global cooperation networks, actively supporting K-ventures and startups to grow into global companies."* This article has been translated by AI. 2026-07-27 09:48:00
-
Celltrion confirms record quarterly profit above preliminary estimate SEOUL, July 27 (AJP) - Celltrion confirmed record second-quarter earnings on Monday that came in above its own preliminary estimate, as newer, higher-margin biosimilars and faster cost improvements outpaced the company's initial reckoning. Final audited revenue rose 45 percent from a year earlier to 1.39 trillion won ($953 million), while operating profit jumped 86.3 percent to 451.8 billion won, the biosimilar maker said in a regulatory filing. Both figures topped the preliminary numbers released on July 3, by about 93.7 billion won and 21.8 billion won respectively. Sales of newer products soared 76 percent year-on-year, lifting their share of total biologics revenue to 65 percent, up from the 60 percent-plus cited in the preliminary report. The company, which has launched 11 biosimilars globally, aims to build an 18-product portfolio by 2030, adding cancer and autoimmune treatments. It reaffirmed full-year targets of 5.3 trillion won in sales and 1.8 trillion won in operating profit, and said it now expects to exceed them. "This quarter confirmed our cash-generating power and business competitiveness, having achieved an operating margin above 30 percent even after absorbing R&D investment for future growth," said a Celltrion spokesperson, adding the company would keep reinvesting biosimilar cash flow into new drugs. Shares of Celltrion traded at 182,900 won per stock on 9:44 a.m., 2.96 percent higher than the previous session. 2026-07-27 09:44:54 -
KB Financial Group Establishes $1.5 Billion Unicorn Fund to Support Advanced Industries KB Financial Group is launching a fund worth 1.5 trillion won (approximately $1.5 billion) to foster advanced strategic industries such as semiconductors, artificial intelligence (AI), and robotics.On July 24, KB Financial Group held its fourth 'Productive Finance Council' meeting to review the progress of its productive finance initiatives, the group announced on July 27.During the meeting, it was decided to establish the 'KB National Growth Unicorn Scale-Up Fund' with a total size of 1.5 trillion won. The fund will be entirely financed by KB Financial affiliates, with management handled by KB Securities' Private Equity Growth Investment Division. Key investment targets will include companies in AI, semiconductors, secondary batteries, aerospace, mobility, robotics, and biotechnology.In line with the government's 'Three Major Mega Projects' and the National Growth Fund policy, KB Financial has also developed financial support measures for investments in semiconductors, power, infrastructure, and physical AI companies, as well as AI data centers. The group plans to enhance comprehensive financial support by identifying innovative small and medium-sized enterprises located in various regions through its Corporate and Investment Banking (CIB) Center, which specializes in corporate finance and securities collaboration.Additionally, the council discussed transitioning from traditional corporate evaluations based on financial statements and past performance to a culture of assessing companies based on their technological capabilities and future growth potential.Kim Sung-hyun, head of KB Financial's CIB Market Division, stated, "We need to expand our role as a partner that grows alongside advanced strategic industry companies, moving beyond traditional loan-based financial support for conventional industries. We will strengthen our capabilities to understand industries and companies and evaluate their technological strengths and future growth values." 2026-07-27 09:44:00
-
Dongyang Moves to New Headquarters in Mapo, Enhancing Group Collaboration Eugene Group's subsidiary Dongyang has relocated to a new headquarters in Mapo, Seoul. On July 27, Dongyang announced that it has created a smart and efficient workspace at its new headquarters, themed "Work Anywhere." The facility covers approximately 1,450 square meters. All meeting rooms are equipped with video conferencing systems to facilitate smooth collaboration and decision-making. Additionally, the office features focus rooms for concentrated work, a T-Care Room for health management, and phone booths for private calls, catering to various individual needs. Key areas such as meeting rooms, executive offices, and storage are designed in a modular format, allowing for quick reconfiguration as needed. A Dongyang representative stated, "We focused on enhancing work immersion and promoting communication between organizations. We expect that this new work environment will continuously improve collaboration and decision-making efficiency." Meanwhile, Eugene Group's real estate asset management firm, Eugene REITs Management, purchased the former Korea Post Pension Management building in January to serve as a consolidated headquarters for the group. Following Dongyang's move, other major subsidiaries will relocate sequentially to enhance collaboration and improve operational efficiency and asset utilization. At the same time, Eugene REITs Management aims to expand its real estate asset management business, targeting 1 trillion won in managed assets by 2028.* This article has been translated by AI. 2026-07-27 09:44:00
-
GC Green Cross Submits IND for Phase 2 Clinical Trial of COVID-19 mRNA Vaccine GC Green Cross has been selected for the government's messenger ribonucleic acid (mRNA) vaccine development support project. The company submitted an Investigational New Drug (IND) application for a Phase 2 clinical trial to the Ministry of Food and Drug Safety, aiming to accelerate the development of a domestic mRNA vaccine.On July 27, GC Green Cross announced that it has been chosen as the company to conduct the Phase 2 clinical research project under the 'Pandemic Preparedness mRNA Vaccine Development Support Project' led by the Korea Disease Control and Prevention Agency and the Korea Health Industry Development Institute.Additionally, on July 24, the company submitted the IND for its COVID-19 mRNA vaccine candidate, 'GC4006A,' for the Phase 2 trial.This initiative is part of a government project aimed at achieving self-sufficiency in COVID-19 vaccines, which have been entirely imported, and securing the capability to develop domestic mRNA vaccines to respond to future pandemics. As part of this project, GC Green Cross will receive funding for clinical research and plans to obtain approval for the COVID-19 mRNA vaccine by 2028.According to the submitted plan, the Phase 2 trial will evaluate the optimal clinical dosage and immunogenicity of GC4006A in healthy adults aged 19 to 85, comparing it directly with an active control group.The lipid nanoparticle (LNP) technology, which safely delivers mRNA to cells, is also considered a key component.GC4006A is the first pipeline to enter the clinical stage using the mRNA-LNP platform developed by GC Green Cross. The company expects to validate the competitiveness and scalability of its platform technology through this clinical trial.GC Green Cross was selected as a supporting company for the Phase 1 clinical study of the same project at the end of last year and is currently conducting the Phase 1 trial. The company has submitted one-month results on safety and tolerability for healthy adults aged 19 to 64 to the Ministry of Food and Drug Safety and plans to initiate the Phase 2 trial within the year, with an IND application for Phase 3 expected in the second half of next year.Lee Jae-woo, head of the development division at GC Green Cross, stated, "mRNA platform technology is a key technology that enables rapid vaccine development and supply in the event of future pandemics. Through this project, we aim to contribute to domestic vaccine self-sufficiency and secure globally competitive independent technology."* This article has been translated by AI. 2026-07-27 09:44:00